catalpol has been researched along with Neurodegenerative Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Deng, C; Meng, S; Meng, Z | 1 |
| Bhattamisra, SK; Choudhury, H; Koh, HM; Lim, SY; Pandey, M | 1 |
| Bi, J; Hinchliffe, T; Jiang, B; Shen, RF; Tian, XS; Xia, Y | 1 |
| Hu, Y; Liu, Q; Liu, S; Wang, Z; Xia, Z; Zhang, R | 1 |
| An, LJ; Chen, J; Duan, YL; Jiang, B; Jiang, L; Tian, YY | 1 |
2 review(s) available for catalpol and Neurodegenerative Diseases
| Article | Year |
|---|---|
Molecular and Biochemical Pathways of Catalpol in Alleviating Diabetes Mellitus and Its Complications.
Topics: Animals; Antioxidants; Cell Differentiation; Cell Proliferation; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Homeostasis; Humans; Hypoglycemic Agents; Iridoid Glucosides; Liver; Mice; Muscle, Skeletal; Neurodegenerative Diseases; NF-kappa B; NF-kappa B p50 Subunit; Osteoblasts; Pancreas; Phosphatidylinositol 3-Kinases; Phosphoenolpyruvate Carboxykinase (ATP); Rehmannia; Retina; Signal Transduction | 2021 |
Catalpol: a potential therapeutic for neurodegenerative diseases.
Topics: Animals; Humans; Iridoid Glucosides; Molecular Structure; Neurodegenerative Diseases; Neuroprotective Agents; Rehmannia | 2015 |
3 other study(ies) available for catalpol and Neurodegenerative Diseases
| Article | Year |
|---|---|
Catalpol Mitigates Alzheimer's Disease Progression by Promoting the Expression of Neural Stem Cell Exosomes Released miR-138-5p.
Topics: Alzheimer Disease; Exosomes; Humans; MicroRNAs; Neural Stem Cells; Neurodegenerative Diseases | 2023 |
Catalpol ameliorates beta amyloid-induced degeneration of cholinergic neurons by elevating brain-derived neurotrophic factors.
Topics: Amyloid beta-Peptides; Animals; Brain; Brain-Derived Neurotrophic Factor; Cells, Cultured; Choline O-Acetyltransferase; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Glucosides; Iridoid Glucosides; Iridoids; Learning; Memory; Mice; Mice, Inbred ICR; Neurites; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic | 2009 |
Catalpol protects dopaminergic neurons from LPS-induced neurotoxicity in mesencephalic neuron-glia cultures.
Topics: Animals; Cells, Cultured; Coculture Techniques; Dopamine; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Glucosides; Inflammation; Iridoid Glucosides; Iridoids; Lipopolysaccharides; Mesencephalon; Mice; Nerve Degeneration; Neurodegenerative Diseases; Neuroglia; Neurons; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Synthase Type II; Reactive Oxygen Species; Tumor Necrosis Factor-alpha | 2006 |